v1
Short-acting beta-adrenergic antagonist esmolol given at reperfusion improves survival after prolonged ventricular fibrillation.
Identifier:nobleid.org/w1/20260515/0AFCCFFD
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/0AFCCFFD)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →